2026-01-20 - Analysis Report
**Company Overview:**
Albemarle is a lithium mining equipment and chemicals company.

**Return Rate Comparison:**

| Stock        | Cumulative Return |
|-------------|-------------------|
| ALB (Review) | 45.47%            |
| VOO (Comparison) | 93.30%            |
| Divergence | -47.80            |

The cumulative return of Albemarle (ALB) is 45.47%, while the comparison stock (S&P 500, VOO) has a cumulative return of 93.30%. The divergence is -47.80, indicating a lower cumulative return for ALB compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -10.0% | 35.3% | -14.0% | 1.2 | 9.1B |
| 2017-2019  | -37.0% | 35.3% | -54.0% | 1.2 | 8.6B |
| 2018-2020  | 50.0% | 29.5% | 29.0% | 1.2 | 17.4B |
| 2019-2021  | 140.0% | 29.5% | 96.0% | 1.3 | 27.5B |
| 2020-2022  | 134.0% | 28.5% | 136.0% | 1.3 | 25.5B |
| 2021-2023  | -26.0% | 53.3% | -27.0% | 1.5 | 17.0B |
| 2022-2024  | -139.0% | 68.7% | -158.0% | 1.5 | 10.1B |
| 2023-2025  | -165.0% | 74.5% | -228.0% | 1.8 | 16.6B |

The Alpha, Beta analysis suggests that Albemarle has shown varying levels of performance across different periods, with the highest Alpha (96.0%) and Beta (1.3) observed in the 2019-2021 period. The 2023-2025 period showed the lowest Alpha (-228.0%) and highest Beta (1.8).

**Recent Stock Price Fluctuations:**

|  | Value |
| --- | --- |
| Close | $163.04 |
| Last-market | $163.04 (previousClose: $173.78, change: -$6.18) |
| 5-day SMA | $172.11 |
| 20-day SMA | $154.75 |
| 60-day SMA | $127.79 |

The recent stock price fluctuations indicate a decrease in price, with a -6.18% change. The 5-day SMA is higher than the current price, indicating a potential upward trend. The 20-day SMA is lower, while the 60-day SMA is significantly lower, suggesting a potential downward trend.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis:**

| Indicator | Value |
| --- | --- |
| RSI | 59.93 |
| PPO | 0.29 |
| Expected Return | 2.80% |
| Market Risk Indicator (MRI) | 0.80 |

The RSI of 59.93 indicates a neutral market condition. The PPO of 0.29 suggests a potential buy signal. The Expected Return of 2.80% and Market Risk Indicator (MRI) of 0.80 suggest a medium risk investment.

**Recent News and Significant Events:**

* Albemarle (ALB) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
* Albemarle (NYSE:ALB) Shares Gap Down - Here's Why - MarketBeat
* 'Influx Of Investor Interest' On Lithium Sends Albemarle To 2-Year Highs - Investor's Business Daily
* Here's Why Albemarle Stock Powered Higher Today - The Motley Fool
* Does Albemarle (ALB) Price Reflect Its Recent 71% One Year Share Gain? - simplywall.st
* Why Albemarle (ALB) is a Top Momentum Stock for the Long-Term - Nasdaq

**Analyst Opinions:**

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 2.23 (~Buy)
	+ Opinions: 23
	+ Target Price (avg/high/low): 151.40 / 210.00 / 80.00

**Recent Earnings Analysis:**

| Date | EPS | Revenue |
| ---: | :--- | :------ |
| 2025-11-05 | -1.72 | $1.31B |
| 2025-08-04 | -0.16 | $1.33B |
| 2025-04-30 | $0 | $1.08B |
| 2024-11-06 | -9.45 | $1.35B |
| 2025-11-05 | -9.45 | $1.35B |

The recent earnings analysis suggests a mixed performance, with a decrease in EPS and revenue in some quarters and an increase in others.

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.31B | 8.99% |
| 2025-06-30 | $1.33B | 14.80% |
| 2025-03-31 | $1.08B | 14.51% |
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |

The revenue and profitability analysis suggests a mixed performance, with a decrease in profit margin in the 2024-09-30 quarter and an increase in other quarters.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.00B | -1.61% |
| 2025-06-30 | $10.24B | 0.22% |
| 2025-03-31 | $10.03B | 0.41% |
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |

The capital and profitability analysis suggests a mixed performance, with a decrease in ROE in the 2024-09-30 quarter and an increase in other quarters.

**Comprehensive Analysis (Summary):**
Albemarle's performance has been mixed, with varying levels of Alpha, Beta, and return on investment across different periods. The recent stock price fluctuations indicate a potential downward trend, while the RSI and PPO analysis suggest a neutral market condition and a potential buy signal. The expected return and MRI suggest a medium risk investment. The earnings analysis, revenue and profitability analysis, and capital and profitability analysis suggest a mixed performance. Recent news and significant events may also be affecting the stock price.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.